Neuromuscular II (Muscle, NMJ, Autonomic) Flashcards
Triggers of hypOkalemic and hypERkalemic periodic paralysis.
HypOkalemic: exercise, emotional stress, cold, carbohydrates, ethanol
HypERkalemic: Resting after exercising and fasting
(ER = REst)
Genes for hypOkalemic and hypERkalemic periodic paralysis.
HypOkalemic: CACNA1S (type 1) and SCN4A( type 2) - both AD
HypERkalemic: SCN4A, AD
(Note neither are K channels - unlike Andersen-Tawil, and different mutations in SCN4A can cause each)
Syndrome with
- Hypokalemic periodic paralysis,
- Ventricular arrhythmias (long QT)
- Dysmorphic features (mcrognathia, low set ears, widely spaced eyes, high arch or cleft palate, long narrow head)
Genetic cause?
Andersen-Tawil syndrome.
KCNJ2 mutation (an inward rectifier in skeletal and cardiac muscle), AD
Which muscle fibers are preferentially atrophic in steroid myopathy?
Type II (fast)
Congenital myopathy with significant prosis, extraocular muscle weakness, and bulbar weakness.
Centronuclear myopathy
(Comes in 3 forms: 1) AR slowly progressive infantile/early childhood type, 2) severe X-linked neonatal type, and 3) milder adult-onset AD type
(Myotubular myopathy is the most common form and is a severe X-linked form)
Mechanism of action of LEMS
Antibodies against presynaptic V-gated Ca2+ channels
Mechanism of action of botulinum toxin
Inhibiting exocytosis of presynaptic ACh vesicles
Patterns of weakness in myotonic dystrophies type 1 and 2
Genetic cause for each
Type 1: Distal weakness and ptosis/facial weakness
AD CTG repeat in DMPK gene (myotonic dystrophy protein kinase)
Type 2: Proximal weakness
AD CCTG repeat (tetranucleotic repeat) in CNBP gene (ZNF9 Zn-finger protein)
(Bigger muscles = bigger number (2 v 1) and bigger repeat (4 v 3)
Categories of congenital muscular dystrophy (CMD) (muscular dystrophies presenting at birth or in early infancy)
1) Collagenopathies (including Ullrich’s CMD and Bethlem myopathy)
2) Merosinopathies (including laminin-alpha-2-related CMDs)
3) Dystroglycanopathies (including Fukuama CMD, muscle-eye-brain disease, and Walker-Wurburg syndrome)
(In general, due to sarcolemmal membrane proteins or membrane-supporting structures)
Muscular dystrophy presenting as floppy baby with skeletal muscle and bulbar weakness, as well as contractures, eye abnormalities and CNS abnormalities (seizures, developmental delay)
Genetic cause
Fukuyama-type congenital muscular dystrophy (FCMD) (A dystroglycanopathy CMD)
AR mutation in fukutin gene, leads to reduced alpha-dystroglycan
(Contrast to laminin-alpha-2 deficiency, merinopathy with floppy baby and contractures, but preserved intelligence and sparing of EOM/facial muscles)
Muscular dystrophy presenting as floppy baby with truncal and axial weakness, as well as contractures and sometimes seizures, but with preserved intelligence and sparing of extraocular and facial muscles.
Genetic cause
Laminin-alpha-2 deficiency, a merosinopathy
Mutation in laminin-alpha-2 gene which encodes protein merosin
(Contrast to Fukuyama-type congenital muscular dystrophy (FCMD), A dystroglycanopathy CMD, which also has floppy baby and then contractures, but has intellectual disability and EOM/facial muscle weakness)
Slowly progressive muscular dystrophya that preferentially involves upper arms (but sparing deltoids) and winged scapula, as well as facial muscle weakness, lower abdoinal muscles, and weak dorsiflexion with preserved plantarflexion
Genetic cause
Fascioscapulohumeral muscular dystrophy (FSHD)
(It’s in the name: facial weakness, winged scapula, upper arm atrophy around the humerus)
AD mutation due to deletions in D4Z4 sequence
Muscular dystrophy presenting with dysphagia, dysphonia, slowly progressive ptosis, and late EOM weakness.
Genetic cause
Oculopharyngeal muscular dystrophy (OPMD; it’s in the name)
AD GCG trinucleotide repeat in poly-A-binding protein 2 gene 9chromosome 14q11)
Syndrome with exercise-induced muscle weakness and cramps which may improve with brief rest - “second wind phenomenon.”
Genetic cause
Similar presentation syndrome with hemolysis and gouty arthritis
McArdle’s disease (a glycogen storage disease)
Myophosphorylase deficiency (This enzyme helps convert glycogen to glucose-6-phosphate, so will be less able to release glucose to replete stores)
Similar syndrome: Tarui disease, glycogen storage disease due to phosphofructokinase (PFK) deficiency (PFK helps convert glucose-6-phosphate to glucose-1-phosphate for use) (also leads to RBC problems)
Syndrome with myotonia especially prominent in eyelids that is worsened with repeated exercise (no “warm up” phenomenon).
Genetic cause
Paramyotonia congenita
AD disorder of SCN4A (same gene implicated in hypERkalemic periodic paralysis type 2, hypOkalemic periodic paralysis, and congenital myasthenic syndrome 16)
Genetic distal myopathy with initial presentation with foot drop and later involvement of distal arms, sparing proximal and bulbar muscles, with rimmed vacuoles on muscle biopsy and tubular filaments on EM (similar to inclusion body myositis, but without inflammation)
Genetic cause
Nonaka myopathy
AR myopathy due to GNE gene
(Contrast with Miyoshi myopathy, which classically presents with plantarflexion weakness (posterior compartment of lower leg)
Genetic, early onset proximal myopathy with risk of malignant hyperthermia with anesthesia
Genetic cause
Central core myopathy (NAD staining while show central pallor due to absence of mitochondria)
AD mutation in RYR1
Acute generalized autonomic failure developing over weeks.
Associated lab test?
Autonomic ganglionopathy aka acute pandysautonomia.
Antibody against ganglionic nicotinic AChR (seen in 1/2 of pts) (can in some cases be paraneoplastic)